1
Return

Evaluation of Ethyl Cellulose–Ethanol Ablation in a Human-Sized 3D Construct of High-Grade Cervical Dysplasia

delete2026-06-22
delete0
delete
OA
AI
G
Gatha Adhikari
A
Alina Sharma
K
Kaitlin C. Fogg
J
Jenna L. Mueller *
DOI:10.1002/jbm.a.70110delete
deleteOriginal
deleteShare
deleteSave
View PDF
Abstract

Abstract

En 中文
Current preclinical models for cervical dysplasia rely on animal systems that poorly mimic human anatomy. To address this and align with emerging initiatives to reduce animal experimentation, we developed a human-sized, 3D in vitro model of high-grade cervical dysplasia. The construct integrates normal human fibroblasts, keratinocytes, and SiHa cancer cells within a gelatin methacrylate (GelMA) hydrogel, engineered with a cervical “os” and asymmetric lesion to replicate native human cervical architecture. We utilized this platform to evaluate the efficacy and safety of ethyl cellulose–ethanol (EC–ethanol), a novel ablation therapy designed to mitigate the off-target leakage associated with traditional ethanol injections. While control injections of pure ethanol resulted in widespread, non-specific necrosis (approximately 99% cell death), EC–ethanol successfully formed a localized gel depot. High-resolution mapping of the ablation zone demonstrated that EC–ethanol significantly concentrated cytotoxicity within the dysplastic lesion while preserving surrounding healthy tissue. Margin analysis revealed a sharp therapeutic gradient, with cell death normalizing to background levels within approximately 2 mm of the injection site. These findings validate the translational potential of EC–ethanol as a spatially precise intervention and demonstrate the utility of macro-scale 3D models as powerful, ethical alternatives to animal testing for optimizing local drug delivery.
Keywords:
3D in vitro model
cervical dysplasia
ethanol ablation
ethyl cellulose
new approach methods
AI Summary

AI Summary

Key information extracted from the uploaded paper, including a brief overview, abstract, background, key highlights, visual analysis, and future outlook.

Journal

Journal of Biomedical Materials Research Part A cover
Journal of Biomedical Materials Research Part A
IF:
3.9
Papers:
7.8K
Citations:
1.6W

Organization

O
Oregon State University
Scholars:
1.6W
Papers: 1.5W
Citations: 2.4W
U
university of maryland
Scholars:
4.0K
Papers: 1.9K
Citations: 1
Cited Papers

Cited Papers

Citing Papers

Citing Papers